Literature DB >> 35005067

Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

Heather M Holden1, Corrin N Schweer1, Alexander I Tröster1.   

Abstract

INTRODUCTION: Younger age of onset and mild cognitive impairment (MCI) are both independently associated with poorer quality of life (QOL) in Parkinson's disease (PD).
OBJECTIVES: The primary objective was to determine whether MCI differentially impacts QOL in young-onset PD (YOPD) and typical-onset PD (TOPD).
METHODS: YOPD patients (n = 77) were diagnosed at age 50 or younger, TOPD (n = 77) were diagnosed after age 50, and the groups were matched for cognitive status, education, and disease duration. Patients' cognitive status was classified as MCI or cognitively normal (CN) based on MDS Level II criteria. QOL was assessed using the Parkinson's Disease Questionnaire (PDQ-39). ANCOVAs were conducted for each PDQ-39 subscale, with age of onset and cognitive status as between-subjects factors and several covariates included.
RESULTS: An interaction for the Cognition domain revealed that in TOPD, PD-MCI patients reported poorer QOL than CN patients, whereas there was no effect of MCI on cognitive satisfaction in YOPD. There was a main effect of age on Emotional Well-Being, as YOPD reported poorer QOL than TOPD in this domain. There were main effects of cognitive status, with PD-MCI patients reporting worse QOL than CN patients in the domains of Social Support, Communication, ADLs, and Mobility.
CONCLUSIONS: The interaction revealed that PD-MCI has a greater impact on degree of cognitive concerns ("cognitive QOL") in TOPD versus YOPD. A more nuanced understanding of the effects of age of onset, MCI, and their interactions on QOL in PD will inform interventions aimed at improving quality of life in this population.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; mild cognitive impairment; quality of life; young onset

Year:  2021        PMID: 35005067      PMCID: PMC8721826          DOI: 10.1002/mdc3.13353

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  17 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

Review 2.  Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism.

Authors:  Anette Schrag; Jonathan M Schott
Journal:  Lancet Neurol       Date:  2006-04       Impact factor: 44.182

Review 3.  Young-onset Parkinson's disease: Its unique features and their impact on quality of life.

Authors:  Raja Mehanna; Joseph Jankovic
Journal:  Parkinsonism Relat Disord       Date:  2019-06-01       Impact factor: 4.891

4.  Quality of life in young- compared with late-onset Parkinson's disease.

Authors:  M Duleeka W Knipe; Mirdhu M Wickremaratchi; Emma Wyatt-Haines; Huw R Morris; Yoav Ben-Shlomo
Journal:  Mov Disord       Date:  2011-05-13       Impact factor: 10.338

5.  Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study.

Authors:  Yilin Tang; Xiaoniu Liang; Linlin Han; Fang Peng; Bo Shen; Huiling Yu; Yan Shen; Cong Shen; Jintai Yu; Jian Wang
Journal:  J Parkinsons Dis       Date:  2020-06-18       Impact factor: 5.568

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 7.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

8.  Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease.

Authors:  William Reginold; Sarah Duff-Canning; Christopher Meaney; Melissa J Armstrong; Susan Fox; Brandon Rothberg; Cindy Zadikoff; Nancy Kennedy; David Gill; Paul Eslinger; Fred Marshall; Mark Mapstone; Kelvin L Chou; Carol Persad; Irene Litvan; Benjamin Mast; David Tang-Wai; Anthony E Lang; Connie Marras
Journal:  Dement Geriatr Cogn Disord       Date:  2013-06-15       Impact factor: 2.959

9.  Fear of Dementia in the General Population: Findings from the German Socio-Economic Panel (GSOEP).

Authors:  André Hajek; Hans-Helmut König
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; David P Breen; Tien K Khoo; Caroline H Williams-Gray; Roger A Barker; Daniel Collerton; John-Paul Taylor; David J Burn
Journal:  Parkinsonism Relat Disord       Date:  2016-04-11       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.